Tobias Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$578K Sell
482
-13
-3% -$13.3K 0.07% 84
2026
Q1
$456K Sell
495
-93
-16% -$94.3K 0.06% 90
2025
Q4
$632K Sell
588
-95
-14% -$90.8K 0.09% 85
2025
Q3
$521K Buy
683
+109
+19% +$81.1K 0.08% 86
2025
Q2
$448K Sell
574
-3
-0.5% -$2.33K 0.08% 86
2025
Q1
$477K Buy
577
+270
+88% +$225K 0.09% 74
2024
Q4
$237K Buy
307
+12
+4% +$9.94K 0.05% 100
2024
Q3
$261K Buy
295
+8
+3% +$7.19K 0.05% 89
2024
Q2
$260K Buy
+287
New +$230K 0.06% 85
2023
Q3
– Sell
-766
Closed -$359K – 93
2023
Q2
$359K Buy
+766
New +$321K 0.1% 68
2020
Q1
– Sell
-8
Closed -$1K – 176
2019
Q4
$1K Buy
+8
New +$927 ﹤0.01% 271

Other funds holding LLY

Tobias Financial Advisors's LLY Position: Q2 2026 in Review

Tobias Financial Advisors reduced its Eli Lilly (LLY) stake by 2.6% in Q2 2026, selling an estimated $13.3K and leaving 482 shares worth $578K. The position accounts for 0.07% of the portfolio, ranked #84.

Tobias Financial Advisors first reported a position in LLY in Q4 2019 and has held it in 11 quarters since. The position peaked at $632K in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tobias Financial Advisors held 482 shares of Eli Lilly worth $578K as of Q2 2026.
  • Tobias Financial Advisors sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 0.07% of Tobias Financial Advisors's portfolio in Q2 2026, its #84 holding.
  • Tobias Financial Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 11 quarters since.
  • Tobias Financial Advisors's Eli Lilly position peaked at $632K in Q4 2025.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tobias Financial Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.